220896-14-0 Usage
General Description
6-chloro-1H-pyrrolo[2,3-b]pyridin-2(3H)-one is a chemical compound with the molecular formula C7H4ClN2O. It is a heterocyclic compound with a pyrrolopyridinone core and a chlorine substituent. 6-chloro-1H-pyrrolo[2,3-b]pyridin-2(3H)-one has potential applications in medicinal chemistry and drug development, as it has been studied for its potential pharmacological activities. Its structure and properties make it useful for designing new compounds with biological activity, and it has been investigated for its potential as an antitumor agent. The synthesis and characterization of 6-chloro-1H-pyrrolo[2,3-b]pyridin-2(3H)-one have been the subject of research in the fields of organic and medicinal chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 220896-14-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,0,8,9 and 6 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 220896-14:
(8*2)+(7*2)+(6*0)+(5*8)+(4*9)+(3*6)+(2*1)+(1*4)=130
130 % 10 = 0
So 220896-14-0 is a valid CAS Registry Number.
InChI:InChI=1/C7H5ClN2O/c8-5-2-1-4-3-6(11)10-7(4)9-5/h1-2H,3H2,(H,9,10,11)
220896-14-0Relevant articles and documents
Indolin-2-one p38α inhibitors II: Lead optimisation
Eastwood, Paul,González, Jacob,Gómez, Elena,Caturla, Francisco,Balagué, Cristina,Orellana, Adelina,Domínguez, María
, p. 5270 - 5273 (2011/10/09)
Optimisation of a series of indolin-2-one p38α inhibitors was achieved via both blocking of a potential metabolic 'hot spot' and by increasing overall polarity of the lead series leading to non-cytotoxic compounds which showed improved oral bioavailabilities in the rat.
3-(anilinomethylene) oxindoles
-
Page column 70-71, (2010/02/04)
The present invention relates generally to novel amine substituted oxindole compounds and compositions. Such compounds and compositions have utility as pharmacological agents in treating diseases or conditions alleviated by the inhibition or antagonism of